Current Understanding of the Molecular and Cellular Pathology of Diabetic Retinopathy

Overview

Journal Nat Rev Endocrinol

Specialty Endocrinology

Date 2021 Jan 20

PMID 33469209

Citations 178

Authors

David A Antonetti

Paolo S Silva

Alan W Stitt

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus has profound effects on multiple organ systems; however, the loss of vision caused by diabetic retinopathy might be one of the most impactful in a patient's life. The retina is a highly metabolically active tissue that requires a complex interaction of cells, spanning light sensing photoreceptors to neurons that transfer the electrochemical signal to the brain with support by glia and vascular tissue. Neuronal function depends on a complex inter-dependency of retinal cells that includes the formation of a blood-retinal barrier. This dynamic system is negatively affected by diabetes mellitus, which alters normal cell-cell interactions and leads to profound vascular abnormalities, loss of the blood-retinal barrier and impaired neuronal function. Understanding the normal cell signalling interactions and how they are altered by diabetes mellitus has already led to novel therapies that have improved visual outcomes in many patients. Research highlighted in this Review has led to a new understanding of retinal pathophysiology during diabetes mellitus and has uncovered potential new therapeutic avenues to treat this debilitating disease.

Citing Articles

Chronic intermittent hypoxia disrupts protective microgliosis in ischemic proliferative retinopathy.

Yang T, Ronning K, Augustin S, Blond F, Nous C, Argyriou F J Neuroinflammation. 2025; 22(1):82.

PMID: 40087728 DOI: 10.1186/s12974-025-03392-9.

GPR30-driven fatty acid oxidation targeted by ginsenoside Rd maintains mitochondrial redox homeostasis to restore vascular barrier in diabetic retinopathy.

Tang K, Huang C, Huang Z, Wang Z, Tan N Cardiovasc Diabetol. 2025; 24(1):121.

PMID: 40087616 DOI: 10.1186/s12933-025-02638-3.

MAP4K4 aggravates microvascular anomalies in diabetic retinopathy in a YTHDF2-dependent manner.

Yang Q, Zhu P, Wen Y, Zhang R, Chen W, Huang X Diabetologia. 2025; .

PMID: 40072537 DOI: 10.1007/s00125-025-06398-3.

The causal effect of glaucoma and diabetic retinopathy: a Mendelian randomization study.

Chen S, Lin M, Hong Y Diabetol Metab Syndr. 2025; 17(1):80.

PMID: 40045419 PMC: 11881510. DOI: 10.1186/s13098-025-01652-5.

Lipid profile in the aqueous humor of diabetic macular edema patients.

Su M, Song Q, Cheng R, Zhang Y, Sun X, Jiang F Front Med (Lausanne). 2025; 12:1541360.

PMID: 40027899 PMC: 11868265. DOI: 10.3389/fmed.2025.1541360.

References

Ogurtsova K, da Rocha Fernandes J, Huang Y, Linnenkamp U, Guariguata L, Cho N . IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40-50. DOI: 10.1016/j.diabres.2017.03.024. View

Ajlan R, Silva P, Sun J . Vascular Endothelial Growth Factor and Diabetic Retinal Disease. Semin Ophthalmol. 2016; 31(1-2):40-8. DOI: 10.3109/08820538.2015.1114833. View

Solomon S, Chew E, Duh E, Sobrin L, Sun J, VanderBeek B . Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017; 40(3):412-418. PMC: 5402875. DOI: 10.2337/dc16-2641. View

Kohner E, Patel V, Rassam S . Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes. 1995; 44(6):603-7. DOI: 10.2337/diab.44.6.603. View

Roy S, Ha J, Trudeau K, Beglova E . Vascular basement membrane thickening in diabetic retinopathy. Curr Eye Res. 2010; 35(12):1045-56. DOI: 10.3109/02713683.2010.514659. View

Enge M, Bjarnegard M, Gerhardt H, Gustafsson E, Kalen M, Asker N . Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 2002; 21(16):4307-16. PMC: 126162. DOI: 10.1093/emboj/cdf418. View

Klein R, Knudtson M, Lee K, Gangnon R, Klein B . The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008; 115(11):1859-68. PMC: 2761813. DOI: 10.1016/j.ophtha.2008.08.023. View

Browning D, Glassman A, Aiello L, Beck R, Brown D, Fong D . Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2006; 114(3):525-36. PMC: 2585542. DOI: 10.1016/j.ophtha.2006.06.052. View

Gardner T, Larsen M, Girach A, Zhi X . Diabetic macular oedema and visual loss: relationship to location, severity and duration. Acta Ophthalmol. 2009; 87(7):709-13. DOI: 10.1111/j.1755-3768.2009.01545.x. View

10.

Cunha-Vaz J . Mechanisms of Retinal Fluid Accumulation and Blood-Retinal Barrier Breakdown. Dev Ophthalmol. 2017; 58:11-20. DOI: 10.1159/000455265. View

11.

Samuels I, Bell B, Pereira A, Saxon J, Peachey N . Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes. J Neurophysiol. 2014; 113(4):1085-99. PMC: 7132312. DOI: 10.1152/jn.00761.2014. View

12.

Bentley K, Franco C, Philippides A, Blanco R, Dierkes M, Gebala V . The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat Cell Biol. 2014; 16(4):309-21. DOI: 10.1038/ncb2926. View

13.

Desjardins D, Yates P, Dahrouj M, Liu Y, Crosson C, Ablonczy Z . Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats. Invest Ophthalmol Vis Sci. 2016; 57(6):2706-13. PMC: 4874474. DOI: 10.1167/iovs.15-18397. View

14.

Lutty G . Effects of diabetes on the eye. Invest Ophthalmol Vis Sci. 2013; 54(14):ORSF81-7. PMC: 3864380. DOI: 10.1167/iovs.13-12979. View

15.

Wilkinson C, Ferris 3rd F, Klein R, Lee P, Agardh C, Davis M . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110(9):1677-82. DOI: 10.1016/S0161-6420(03)00475-5. View

16.

Abramoff M, Fort P, Han I, Jayasundera K, Sohn E, Gardner T . Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease. Invest Ophthalmol Vis Sci. 2018; 59(1):519-527. PMC: 5786342. DOI: 10.1167/iovs.17-21873. View

17.

Klein B . Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007; 14(4):179-83. DOI: 10.1080/09286580701396720. View

18.

Klein R, Klein B, Moss S, Cruickshanks K . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995; 102(1):7-16. DOI: 10.1016/s0161-6420(95)31052-4. View

19.

Duh E, Sun J, Stitt A . Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. 2017; 2(14). PMC: 5518557. DOI: 10.1172/jci.insight.93751. View

20.

Kady N, Liu X, Lydic T, Syed M, Navitskaya S, Wang Q . ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability. Diabetes. 2018; 67(4):769-781. PMC: 5860862. DOI: 10.2337/db17-1034. View